We are seeking a highly motivated postdoctoral researcher to join our dynamic team in investigating senescent mechanisms and potential therapeutic interventions in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). This exciting opportunity offers a unique chance to contribute to cutting-edge research at the intersection of neurodegenerative diseases and cellular senescence.

Key Responsibilities:

• Conduct research to unravel the role of cellular senescence in ALS and FTD pathogenesis.
• Employ state-of-the-art techniques in molecular biology, cell culture, and neuroscience to study senescence-related pathways.
• Evaluate potential therapeutic interventions targeting senescent mechanisms.
• Collaborate with multidisciplinary teams and participate in data analysis and publication of research findings.

• Ph.D. in neuroscience, cell biology, molecular biology, or related field.
• Strong background in cellular senescence, neurodegenerative diseases, or a related research area.
• Proficiency in experimental techniques such as immunohistochemistry, western blotting, and cell culture.
• Excellent communication and teamwork skills.
• A passion for advancing our understanding of ALS and FTD and developing potential therapies.

We offer competitive salary and benefits, access to cutting-edge research facilities, and a collaborative environment for career growth. Join us in the pursuit of breakthroughs in ALS and FTD research. To apply, please submit your CV, a cover letter outlining your research interests and career goals, and contact information for three references.

Jefferson includes Thomas Jefferson University and Jefferson Health, a dynamic university and health system with broad reach across the Delaware Valley. Jefferson is the second largest employer in Philadelphia and the largest health system in Philadelphia based on total licensed beds.

Through the merger of Thomas Jefferson University and Philadelphia University in 2017, our University includes ten colleges and four schools. We are an NCAA Division II university and an R2 national doctoral university offering undergraduate and graduate-level programs that provide students with a forward-thinking education in architecture, business, design, engineering, fashion and textiles, health, medicine and social science.

Jefferson Health, the clinical arm of Thomas Jefferson University, has grown from a three-hospital academic health center in 2015, to an 18-hospital health system through mergers and combinations that include hospitals at Abington Health, Aria Health, Kennedy Health, Magee Rehabilitation and Einstein Healthcare Network. We have over 50 outpatient and urgent care centers; ten Magnetreg;-designated hospitals (recognized by the ANCC for nursing excellence); the NCI-designated Sidney Kimmel Cancer Center (one of only 70 in the country and one of only two in the region); and one of the largest faculty-based telehealth networks in the country. In 2021, Jefferson Health became the sole owner of HealthPartners Plan, a not-for-profit health maintenance organization in Southeastern Pennsylvania. We are the first health system regionally to create an aligned payer-provider partnership.

Jeffersonrsquo;s mission, vision and values create an organization that attracts the best and the brightest students, faculty, staff, and healthcare professionals, as well as the most visionary leaders to drive exceptional results.

• OUR MISSION: We improve lives.
• OUR VISION: Reimagining health, education and discovery to create unparalleled value
• OUR VALUES: Put People First, Be Bold amp; Think Differently and Do the Right Thing

As an employer, Jeffersonmaintains a commitment to provide equal access to employment. Jefferson values diversity and encourages applications from women, members of minority groups, LGBTQ individuals, disabled individuals, and veterans.